{"id":"https://openalex.org/W2005277174","doi":"https://doi.org/10.1038/ki.1985.28","title":"Results of a controlled drug trial in membranoproliferative glomerulonephritis","display_name":"Results of a controlled drug trial in membranoproliferative glomerulonephritis","publication_year":1985,"publication_date":"1985-02-01","ids":{"openalex":"https://openalex.org/W2005277174","doi":"https://doi.org/10.1038/ki.1985.28","mag":"2005277174","pmid":"https://pubmed.ncbi.nlm.nih.gov/3886998"},"language":"en","primary_location":{"id":"doi:10.1038/ki.1985.28","doi":"https://doi.org/10.1038/ki.1985.28","is_oa":true,"landing_page_url":"https://doi.org/10.1038/ki.1985.28","pdf_url":"https://www.kidney-international.org/article/S0085-2538(15)33375-5/pdf","source":{"id":"https://openalex.org/S97303050","display_name":"Kidney International","issn_l":"0085-2538","issn":["0085-2538","1523-1755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.kidney-international.org/article/S0085-2538(15)33375-5/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107379274","display_name":"Daniel Cattran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Daniel C. Cattran","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036458953","display_name":"Carl J. Cardella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Carl J. Cardella","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103509750","display_name":"Janet Roscoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Janet M. Roscoe","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044922274","display_name":"Richard C. Charron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Richard C. Charron","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015185547","display_name":"Phillips Rance","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Phillip C. Rance","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109558792","display_name":"Susan M. Ritchie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Susan M. Ritchie","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111606985","display_name":"Paul Corey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Paul N. Corey","raw_affiliation_strings":["Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Medicine and Preventive Medicine and Biostatistics, University of Toronto, and The Toronto Glomerulonephritis Study Group, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5107379274"],"corresponding_institution_ids":["https://openalex.org/I185261750"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":7.2548,"has_fulltext":true,"cited_by_count":81,"citation_normalized_percentile":{"value":0.97523928,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"27","issue":"2","first_page":"436","last_page":"441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/membranoproliferative-glomerulonephritis","display_name":"membranoproliferative glomerulonephritis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9419999718666077},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.7739999890327454},{"id":"https://openalex.org/keywords/dipyridamole","display_name":"dipyridamole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/renal-function-decline","display_name":"renal function decline","score":0.7979999780654907},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8270000219345093},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7089999914169312},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5870000123977661},{"id":"https://openalex.org/keywords/natural-history-disease","display_name":"natural history (disease)","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8219501972198486},{"id":"https://openalex.org/C2781036514","wikidata":"https://www.wikidata.org/wiki/Q2299379","display_name":"Membranoproliferative glomerulonephritis","level":4,"score":0.7886696457862854},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6570327281951904},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.618503212928772},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5688754916191101},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5456110835075378},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5306621789932251},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4995901584625244},{"id":"https://openalex.org/C2776890861","wikidata":"https://www.wikidata.org/wiki/Q419374","display_name":"Dipyridamole","level":2,"score":0.4273304343223572},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.41342419385910034},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3203848600387573},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.20238742232322693}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004176","descriptor_name":"Dipyridamole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004176","descriptor_name":"Dipyridamole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005921","descriptor_name":"Glomerulonephritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007677","descriptor_name":"Kidney Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/ki.1985.28","doi":"https://doi.org/10.1038/ki.1985.28","is_oa":true,"landing_page_url":"https://doi.org/10.1038/ki.1985.28","pdf_url":"https://www.kidney-international.org/article/S0085-2538(15)33375-5/pdf","source":{"id":"https://openalex.org/S97303050","display_name":"Kidney International","issn_l":"0085-2538","issn":["0085-2538","1523-1755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International","raw_type":"journal-article"},{"id":"pmid:3886998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3886998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney international","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1038/ki.1985.28","doi":"https://doi.org/10.1038/ki.1985.28","is_oa":true,"landing_page_url":"https://doi.org/10.1038/ki.1985.28","pdf_url":"https://www.kidney-international.org/article/S0085-2538(15)33375-5/pdf","source":{"id":"https://openalex.org/S97303050","display_name":"Kidney International","issn_l":"0085-2538","issn":["0085-2538","1523-1755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney International","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319947","display_name":"Kidney Foundation of Canada","ror":"https://ror.org/019a0gk53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005277174.pdf","grobid_xml":"https://content.openalex.org/works/W2005277174.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W44668037","https://openalex.org/W186935747","https://openalex.org/W1975310659","https://openalex.org/W2005351050","https://openalex.org/W2006318734","https://openalex.org/W2010445968","https://openalex.org/W2016300836","https://openalex.org/W2036810827","https://openalex.org/W2047780153","https://openalex.org/W2077480851","https://openalex.org/W2314429241","https://openalex.org/W2331496244","https://openalex.org/W2396367203","https://openalex.org/W2398144042","https://openalex.org/W2403646116","https://openalex.org/W2407134397","https://openalex.org/W2408606884","https://openalex.org/W2412395313","https://openalex.org/W2417164849","https://openalex.org/W2418608522","https://openalex.org/W2419605174","https://openalex.org/W2425390775","https://openalex.org/W2440402236","https://openalex.org/W2440941006","https://openalex.org/W2464983246","https://openalex.org/W4246391071","https://openalex.org/W6601834967","https://openalex.org/W7122755775"],"related_works":["https://openalex.org/W2058330927","https://openalex.org/W1966123366","https://openalex.org/W5925783","https://openalex.org/W2036810827","https://openalex.org/W2626742650","https://openalex.org/W2039760414","https://openalex.org/W2055415949","https://openalex.org/W2064253265","https://openalex.org/W2420834527","https://openalex.org/W2412395313"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}